Skip to content

Insider · CIK 0001258288

Raymond W Cohen

ceoofficerdirector

Files at AXNX (Axonics, Inc.), KMTS (KESTRA MEDICAL TECHNOLOGIES, LTD.). First filing Oct 1, 2026, latest Oct 1, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $98k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

KMTS: KESTRA MEDICAL TECHNOLOGIES, LTD.

KMTSOct 9, 2026 · close 26.98

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
33Weak
KMTSsell 2
KESTRA MEDICAL TECHNOLOGIES, LTD.
$98k
3,330 shares
-6%+58% from low-1% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 30, 2026KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
SOpen-market sale
Common Shares
-3,330$29.28$98k54,79011 d ago
Sep 9, 2026KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
AGrant or award
Common Shares
+7,217--58,12032 d ago
Nov 15, 2024AXNX
Axonics, Inc.
DDisposition to issuer
Common Stock
-292,731$71.00$21M0Nov 15, 2024
Nov 15, 2024AXNX
Axonics, Inc.
DDisposition to issuer
Performance-Based Restricted Stock Unitsderivative
-31,125$0.00$00Nov 15, 2024
Nov 15, 2024AXNX
Axonics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-196,451$56.81$11M0Nov 15, 2024
Nov 15, 2024AXNX
Axonics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-106,776$69.37$7.4M0Nov 15, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Raymond W Cohen: insider trades and track record | InsiderTell